CRISPR-Cas12 Application for the Detection of Pneumocystis jirovecii in Immunodepression Patients Through Fluorescent...

Area of Science:

• Molecular Biology
• Infectious Diseases
• Diagnostics

Background:

• Pneumocystis jirovecii pneumonia (PJP) is a severe threat to immunocompromised individuals.
• Current PJP diagnostic methods lack sensitivity, specificity, and accessibility, delaying crucial treatment.
• There is a need for rapid, sensitive, and cost-effective PJP detection methods.

Purpose of the Study:

• To develop and evaluate a CRISPR-Cas12-based platform for rapid and sensitive PJP detection.
• To assess the specificity of the CRISPR-Cas12 method against other microorganisms.
• To demonstrate the potential of this platform for public health diagnostic systems.

Main Methods:

• A CRISPR-Cas12 detection platform was developed using guide RNAs targeting P. jirovecii genes (DHPS, β-tubulin, mtLSU rRNA).
• The system was tested for sensitivity and specificity using fluorescence and lateral flow strips, without prior genetic amplification.
• The platform's performance was evaluated in an initial diagnostic application.

Main Results:

• The CRISPR-Cas12 system, particularly targeting the β-tubulin gene, achieved high sensitivity and specificity for P. jirovecii detection within 20-30 minutes.
• The method showed no cross-reactivity with DNA from other microorganisms.
• Detection using lateral flow strips also demonstrated high sensitivity and specificity without amplification.

Conclusions:

• The developed CRISPR-Cas12 platform provides a rapid, sensitive, and specific method for P. jirovecii detection.
• This technology is suitable for resource-limited settings and field applications due to its speed, adaptability, and ease of use.
• CRISPR-Cas12 holds significant potential for integration into public health diagnostic systems for PJP management.